Multimodal Management of Neck and Back Pain in the Emergency Department (Multi-ED)

March 5, 2024 updated by: Duke University

Pilot Study of an Innovative Model to Provide Evidence-Based Multimodal Management of Neck and Back Pain in the Emergency Department (Multi-ED)

The purpose of this study is to assess the feasibility and acceptability of psychologically-informed physical therapy (PIPT) in the ED in a pilot study of ED patients with neck or back pain. We will conduct a single-site, prospective trial comparing the combined program in one group with a usual care-only group. Primary outcomes will focus on feasibility based on recruitment and retention rates, and acceptability based on a 5-point patient satisfaction scale, while secondary outcomes will include pain severity, pain interference, anxiety, physical function, opioid use, repeat ED visits, and hospitalizations at 1 hour and at 24 hours, 1 month and 3 months after ED discharge.

We will use pilot study results to develop a protocol for a larger pragmatic randomized clinical trial designed to rigorously evaluate PIPT in the ED combined with Spine Health follow up for ED patients with neck or back pain. We will perform a process evaluation of our proposed clinical trial study design, including characterizing and quantifying the degree of CBT and PT components used by treating PTs while in the ED and during Spine Health follow up, number of Spine Health visits attended in the first month, and integration into usual ED care. Qualitative interviews will be used to identify facilitators, barriers and potential solutions to intervention and research study procedures based on the patients' experience.

Study Overview

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North Carolina
      • Durham, North Carolina, United States, 27710
        • Duke University Hospital Emergency Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Adults (age 18 years or older),
  • Presented to the ED with pain in the neck and/or back,
  • A diagnosis of musculoskeletal pain as determined by an ED provider,
  • Able to read and understand the consent form in English.

Exclusion Criteria:

  • Suspected to have a non-musculoskeletal cause of pain;
  • Unable to provide informed consent or to comprehend or complete study measures or procedures due to cognitive impairment, including evidence of drug, medication or alcohol intoxication, or due to severe hearing or speech impairment;
  • Unable to safely participate due to critical illness, emergent surgical need, other serious medical condition (including active COVID-19 infection),
  • ED provider judgment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Usual care only
Experimental: Psychologically-Informed Physical Therapy (PIPT)
CBT-trained physical therapist evaluation and treatment with recommendation for Spine Health follow up after ED discharge
The PIPT group will receive evaluation and treatment based on the PT's assessment of the individual patient's clinical presentation and condition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of ED patients eligible for recruitment as measured by patient log
Time Frame: Post implementation, up to 6 weeks
Post implementation, up to 6 weeks
Number of patients enrolled as measured by patient log
Time Frame: Post implementation, up to 6 weeks
Post implementation, up to 6 weeks
Number of patients retained in study as measured by patient log
Time Frame: Post implementation, up to 6 weeks
Post implementation, up to 6 weeks
Number of patients that found treatment satisfactory via satisfactory questionnaire
Time Frame: Post implementation, up to 6 weeks
5 point Likert-scale satisfaction scale
Post implementation, up to 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain Score
Time Frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
11-point Numeric Rating Scale (NRS) for current pain
ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
Change in Anxiety Level
Time Frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
Subjective Units of Discomfort Scales (SUDS)
ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
Change in Function
Time Frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
PROMIS-29
ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
Change in Quality of Life (QoL)
Time Frame: ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
PROMIS-29
ED pre-treatment (baseline); ED post-treatment (1 hour); 24 hours post discharge
Change in pain related distress
Time Frame: ED pre-treatment (baseline); 1 and 3 months post discharge
Optimal Screening for Prediction of Referral and Outcome (OSPRO) tool
ED pre-treatment (baseline); 1 and 3 months post discharge
Change in self efficacy
Time Frame: ED pre-treatment (baseline); 1 and 3 months post discharge
Optimal Screening for Prediction of Referral and Outcome (OSPRO) tool
ED pre-treatment (baseline); 1 and 3 months post discharge
Change in severity of chronic pain
Time Frame: ED pre-treatment (baseline); 1 and 3 months post discharge
Simplified graded chronic pain scale
ED pre-treatment (baseline); 1 and 3 months post discharge
Number of pain medications prescribed
Time Frame: up to 3 months post discharge
as measured by chart review
up to 3 months post discharge
Number of Spine Health referrals for follow up PT
Time Frame: At ED discharge (up to 48 hours)
as measured by chart review
At ED discharge (up to 48 hours)
Number of Spine Health visits for follow up PT
Time Frame: up to 3 months post discharge
as measured by chart review
up to 3 months post discharge
Number of repeat ED visits
Time Frame: up to 3 months post discharge
as measured by chart review
up to 3 months post discharge
Number of patient hospitalizations
Time Frame: up to 3 months post discharge
as measured by chart review
up to 3 months post discharge

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Stephanie Eucker, MD, PhD, Duke University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2022

Primary Completion (Actual)

April 20, 2023

Study Completion (Actual)

July 31, 2023

Study Registration Dates

First Submitted

January 31, 2022

First Submitted That Met QC Criteria

January 31, 2022

First Posted (Actual)

February 2, 2022

Study Record Updates

Last Update Posted (Actual)

March 6, 2024

Last Update Submitted That Met QC Criteria

March 5, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Psychologically-Informed Physical Therapy (PIPT)

3
Subscribe